Reports for TEVA-TAMSULOSIN CR
Brand name
TEVA-TAMSULOSIN CR
Company Name
TEVA CANADA LIMITED
|
Drug Identification Number
02368242 |
Ingredients
TAMSULOSIN HYDROCHLORIDE |
Ingredient Strength
0.4 MG |
ATC Code
G04CA |
ATC Descriptor
DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY |
Status
MARKETED
|
Shortage reports
| Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|
| TEVA-TAMSULOSIN CR | 100 | Resolved | 2020-10-30 | 2021-04-01 | 127616 |
| TEVA-TAMSULOSIN CR | pp 30 | Resolved | 2020-11-06 | 2021-01-28 | 128025 |
| TEVA-TAMSULOSIN CR | PP 30 | Resolved | 2021-02-18 | 2021-05-13 | 134343 |
| TEVA-TAMSULOSIN CR | 100 | Resolved | 2021-04-08 | 2021-05-13 | 137185 |
| TEVA-TAMSULOSIN CR | 100 | Resolved | 2022-05-12 | 2022-12-15 | 160454 |
| TEVA-TAMSULOSIN CR | 30 | Actual shortage | 2023-04-27 | 2024-04-25 | 190785 |
| TEVA-TAMSULOSIN CR | 100 | Resolved | 2023-06-16 | 2023-10-06 | 195078 |
| TEVA-TAMSULOSIN CR | 30 | Resolved | 2023-06-20 | 2023-07-05 | 195827 |
| TEVA-TAMSULOSIN CR | 100 | Actual shortage | 2023-11-03 | 2024-04-11 | 209148 |
Showing 1 to 9 of 9
Discontinuation reports
| Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
|---|
Showing 1 to 0 of 0